Press Releases

Alere is leading the industry in informed, connected healthcare. Explore our news room to see how.

All
  • All
  • Corporate / Financial
  • Cardiometabolic
  • Connected Health
  • Health Information Solutions
  • Infectious Disease
  • Toxicology
  • Women's health
Date Press Release PDF
Dec 15
2015
Alere Inc. Declares Cash Dividend on its Series B Convertible Perpetual Preferred Stock
Nov 19
2015
Alere Inc. Completes Divestiture of BBI Group
Nov 09
2015
Alere’s SD BIOLINE HIV/Syphilis Duo is First Dual Test to Receive WHO Prequalification
Nov 04
2015
Alere Reports Third Quarter 2015 Financial Results
Oct 28
2015
Alere to Report Third Quarter 2015 Financial Results on November 4, 2015
Oct 15
2015
Alere Receives U.S. HHS Approval to Electronically Process Drug Tests for Department of Transportation-Regulated Employees
Oct 01
2015
Quick Test Minimises Unnecessary Antibiotic Prescribing in Primary Care
Sep 28
2015
Alere Expands Commitment to Support Organisation of African First Ladies against HIV/AIDS (OAFLA) in Efforts to Reduce Mother-to-Child Transmission of HIV and Syphilis and Enhance HIV Early Infant Diagnosis
Sep 09
2015
Alere to Participate in Morgan Stanley Global Healthcare Conference
Sep 01
2015
Alere Inc. Declares Cash Dividend on its Series B Convertible Perpetual Preferred Stock
Aug 20
2015
Frost & Sullivan Recognises Alere’s Wide Palette of HIV Diagnostics Products with Cutting-edge Technologies
Aug 13
2015
Alere Partners with Desmond Tutu HIV Foundation to Reduce Impact of Disease on Vulnerable Youth
Aug 05
2015
Alere to Participate in 35th Annual Canaccord Genuity Growth Conference
Aug 04
2015
Alere Reports Second Quarter 2015 Financial Results
Jul 28
2015
Alere to Report Second Quarter 2015 Financial Results on August 4, 2015
Jul 23
2015
Dr. Geoffrey S. Ginsburg Joins Alere Board
Jul 16
2015
Alere Continues to Execute on Core Business Strategy through Agreement to Sell BBI Group and Acquisition of US Diagnostics
Jul 16
2015
Alere Receives FDA CLIA Waiver for Alere™ i Strep A Rapid Molecular Test
Jun 24
2015
Alere Inc. Announces Completion of Offering of $425 Million of Senior Subordinated Notes
Jun 23
2015
Alere Partners with Local and National Stakeholders in Support of National HIV Testing Day
Jun 18
2015
Alere Inc. Announces Refinancing of Senior Secured Credit Facilities
Jun 11
2015
Alere Inc. Announces Pricing of $425 Million Senior Subordinated Notes Offering
Jun 10
2015
Alere Inc. Announces Offering of $425 Million of Senior Subordinated Notes
Jun 02
2015
Alere Announces Broad Initiatives to Help Combat Antibiotic Resistance during White House Antibiotic Stewardship Forum
Jun 01
2015
Alere Inc. Declares Cash Dividend on its Series B Convertible Perpetual Preferred Stock
May 26
2015
Alere Inc. Receives NYSE Notice Regarding Late Form 10-Q Filing
May 22
2015
Alere to Participate in Upcoming Investor Conferences
May 04
2015
Alere to Report First Quarter 2015 Financial Results and Provide Update on May 5, 2015
Apr 06
2015
Alere Inc. Reports Employment Inducement Awards Pursuant to NYSE Rule 303A.08
Apr 02
2015
Alere Receives FDA Clearance for Alere™ i Strep A Rapid Molecular Test
Mar 30
2015
Alere Applauds President’s National Action Plan to Combat Antibiotic-Resistant Bacteria
Mar 23
2015
Alere to Appoint Veteran Finance Executive, James F. Hinrichs, EVP and Chief Financial Officer
Mar 18
2015
Alere and FIND Extend Partnership to Support Development of Rapid Test for Simultaneous Detection of Malaria and Sleeping Sickness
Mar 09
2015
Alere Announces Chief Financial Officer Transition
Mar 05
2015
Alere Inc. to Host Investment Community Meeting
Mar 04
2015
Epocal Honoured with 2015 Employer Excellence Award for Immigrant Recruitment and Integration Programs
Mar 03
2015
Alere Inc. Declares Cash Dividend on its Series B Convertible Perpetual Preferred Stock
Mar 02
2015
Alere Receives IVD CE Mark for Alere™ q HIV-1/2 Detect Assay for Molecular Diagnosis of HIV at the Point of Care
Feb 23
2015
Alere to Present at 35th Annual Cowen and Company Health Care Conference
Feb 18
2015
Innovative Partnership Expanded to Bring to Market Dual Detection Test for Neglected Tropical Diseases
Feb 17
2015
Alere Receives CE Mark for Alere™ HIV Combo
Feb 10
2015
Alere Inc. Announces Fourth Quarter 2014 Results
Feb 03
2015
Alere Schedules Fourth Quarter 2014 Earnings Conference Call
Jan 09
2015
Alere Inc. Completes Divestiture of Alere Health
Jan 07
2015
Alere Receives FDA CLIA Waiver for Alere™ i Influenza A & B Test
Jan 05
2015
Alere to Present at 33rd Annual J.P. Morgan Healthcare Conference

Be Alerted

Stay alerted about our latest news and announcements

Sign Up

©2010-2015 Alere. All rights reserved. The Alere Logo and Alere are trademarks of the Alere group of companies. All other trademarks referenced are trademarks of their respective owners. This website is governed by applicable U.S. laws and governmental regulations. The products and information contained herewith may not be accessible in all countries, and Alere takes no responsibility for such information which may not comply with local country legal process, regulation, registration and usage. Your use of this website and the information contained herein is subject to our Website Terms and Conditions and Privacy Policy. Photos displayed are for illustrative purposes only. Any person depicted in such photographs is a model.